Industry News
Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer...
Dentistry TodayNovember 1, 20192 Mins read